Stock data
Tenax Therapeutics, Inc. (TENX)
Tenax Therapeutics, Inc. (TENX) reported revenue of US$0.00M and net income of -US$52.60M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.00M | — | -US$56.38M | -US$52.60M | — |
| 2024 | US$0.00M | — | -US$19.49M | -US$17.60M | — |
| 2023 | — | — | -US$8.23M | -US$7.71M | — |
| 2022 | — | — | US$11.05M | US$11.05M | — |
| 2021 | — | — | -US$32.73M | -US$32.47M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$17.80M | — |
| 2026-03-31 | US$0.00M | -US$15.72M | — |
| 2025-12-31 | — | -US$15.54M | — |
| 2025-09-30 | — | -US$15.80M | — |
| 2025-06-30 | — | -US$10.85M | — |
| 2025-03-31 | US$0.00M | -US$10.41M | — |
| 2024-12-31 | — | -US$6.27M | — |
| 2024-09-30 | — | -US$3.96M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.